OBJECTIVES: R5-tropic viruses are associated with HIV-1 transmission and predominate during the early stages of infection. X4-tropic populations have been detected in ~50% of patients with late-stage disease infected with subtype B viruses. In this study, we compared the frequency of X4 tropism in individuals infected with HIV-1 CRF14_BG viruses, which have a V3 loop of subtype B, with a control group of individuals infected with subtype B viruses. METHODS: Sixty-three individuals infected with HIV-1 CRF14_BG (n = 31) or subtype B (n = 32) were studied. Similar proportions of newly diagnosed and chronically infected individuals were included in the subtype B and CRF14_BG groups. V3 sequences were obtained and coreceptor tropism was predicted using the Geno2pheno[coreceptor] algorithm. V3 net charge and 11/25 rules were also used for coreceptor prediction. RESULTS: Overall, X4 tropism was more frequent among individuals infected with CRF14_BG viruses (87.1%) than subtype B viruses (34.3%), a difference that was statistically highly significant (P = 0.00001). Importantly, the frequencies among newly diagnosed individuals were 90% and 13.3%, respectively (P = 0.0007). Characteristic amino acids in the V3 loop (T13, M14, V19 and W20) were identified at higher frequencies in CRF14_BG viruses (54%) than subtype B viruses (0%; P < 0.000001). CONCLUSIONS: CRF14_BG is the genetic form with the highest proportion of X4-tropic viruses reported to date in newly diagnosed and chronic infections. This suggests high pathogenicity for CRF14_BG viruses, potentially leading to rapid disease progression. CCR5 antagonists will be ineffective in most CRF14_BG-infected patients, even at early stages of infection.
OBJECTIVES: R5-tropic viruses are associated with HIV-1 transmission and predominate during the early stages of infection. X4-tropic populations have been detected in ~50% of patients with late-stage disease infected with subtype B viruses. In this study, we compared the frequency of X4 tropism in individuals infected with HIV-1 CRF14_BG viruses, which have a V3 loop of subtype B, with a control group of individuals infected with subtype B viruses. METHODS: Sixty-three individuals infected with HIV-1 CRF14_BG (n = 31) or subtype B (n = 32) were studied. Similar proportions of newly diagnosed and chronically infected individuals were included in the subtype B and CRF14_BG groups. V3 sequences were obtained and coreceptor tropism was predicted using the Geno2pheno[coreceptor] algorithm. V3 net charge and 11/25 rules were also used for coreceptor prediction. RESULTS: Overall, X4 tropism was more frequent among individuals infected with CRF14_BG viruses (87.1%) than subtype B viruses (34.3%), a difference that was statistically highly significant (P = 0.00001). Importantly, the frequencies among newly diagnosed individuals were 90% and 13.3%, respectively (P = 0.0007). Characteristic amino acids in the V3 loop (T13, M14, V19 and W20) were identified at higher frequencies in CRF14_BG viruses (54%) than subtype B viruses (0%; P < 0.000001). CONCLUSIONS: CRF14_BG is the genetic form with the highest proportion of X4-tropic viruses reported to date in newly diagnosed and chronic infections. This suggests high pathogenicity for CRF14_BG viruses, potentially leading to rapid disease progression. CCR5 antagonists will be ineffective in most CRF14_BG-infected patients, even at early stages of infection.
Authors: Iulia Niculescu; Simona Paraschiv; Dimitrios Paraskevis; Adrian Abagiu; Ionelia Batan; Leontina Banica; Dan Otelea Journal: AIDS Res Hum Retroviruses Date: 2014-11-04 Impact factor: 2.205
Authors: Javier E Cañada-García; Elena Delgado; Horacio Gil; Sonia Benito; Mónica Sánchez; Antonio Ocampo; Jorge Julio Cabrera; Celia Miralles; Elena García-Bodas; Ana Mariño; Patricia Ordóñez; María José Gude; Carmen Ezpeleta; Michael M Thomson Journal: Front Microbiol Date: 2022-05-27 Impact factor: 6.064
Authors: Aurora Fernández-García; Elena Delgado; María Teresa Cuevas; Yolanda Vega; Vanessa Montero; Mónica Sánchez; Cristina Carrera; María José López-Álvarez; Celia Miralles; Sonia Pérez-Castro; Gustavo Cilla; Carmen Hinojosa; Lucía Pérez-Álvarez; Michael M Thomson Journal: PLoS One Date: 2016-02-22 Impact factor: 3.240
Authors: Juan Ángel Patiño-Galindo; Manoli Torres-Puente; María Alma Bracho; Ignacio Alastrué; Amparo Juan; David Navarro; María José Galindo; Dolores Ocete; Enrique Ortega; Concepción Gimeno; Josefina Belda; Victoria Domínguez; Rosario Moreno; Fernando González-Candelas Journal: Sci Rep Date: 2017-09-14 Impact factor: 4.379
Authors: Elena Delgado; Aurora Fernández-García; Marcos Pérez-Losada; María Moreno-Lorenzo; Ismael Fernández-Miranda; Sonia Benito; Vanessa Montero; Horacio Gil; Silvia Hernáez; Josefa Muñoz; Miren Z Zubero-Sulibarria; Elena García-Bodas; Mónica Sánchez; Jorge Del Romero; Carmen Rodríguez; Luis Elorduy; Elena Bereciartua; Esther Culebras; Icíar Rodríguez-Avial; María Luisa Giménez-Alarcón; Carmen Martín-Salas; Carmen Gómez-González; José J García-Irure; Gema Cenzual; Ana Martínez-Sapiña; María Maiques-Camarero; Lucía Pérez-Álvarez; Michael M Thomson Journal: Sci Rep Date: 2021-06-01 Impact factor: 4.379
Authors: Simona Paraschiv; Leontina Banica; Ionelia Nicolae; Iulia Niculescu; Adrian Abagiu; Raluca Jipa; Andrea-Clemencia Pineda-Peña; Marta Pingarilho; Emil Neaga; Kristof Theys; Pieter Libin; Dan Otelea; Ana Abecasis Journal: PLoS One Date: 2017-10-09 Impact factor: 3.240